ArticleCase reports in oncology

Entrectinib for NTRK Fusion-Positive Metastatic Melanoma Progressing on Combined PD-1 and CTLA-4 Inhibition: A Case Report.

Shaheenah Dawood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.